Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 22 2024

Full Issue

Senators Accuse Pharmaceutical Firms Of Abusing Patent System

But an official from PhRMA, the drug industry’s trade group, said the current patent system has proper "checks and balances." Sen. Lindsey Graham, R-S.C., shot back: "You think it's working? Yeah, well, I don't." Other news from the Hill is on the farm bill and SNAP.

NBC News: Sky-High Drug Prices? Senators Blame Patent Abuse

The drug industry’s top lobbying group on Tuesday faced fierce questioning at a Senate Judiciary Committee hearing that explored whether abuse of the patent system is responsible for keeping prescription drug prices sky-high in the United States. The patent system is meant to reward innovation by allowing drugmakers to exclusively sell new medications on the market for a set period of time — typically 20 years. (Lovelace Jr., 5/21)

In news about the farm bill —

Newsweek: SNAP Benefits Change Backlash Shocks Republican

The chair of the House Committee on Agriculture, which oversees the Supplemental Nutrition Assistance Program (SNAP), is "shocked" at the backlash he's faced after proposing changes to the program. As committee chair, Republican Representative Glenn "GT" Thompson of Pennsylvania will lead the lower chamber's efforts in drafting a new Farm Bill, a comprehensive spending package passed every five to six years that directs U.S. food and agriculture policy. Markup of the House draft of that bill is scheduled for Thursday. (5/21)

Politico: Hemp And Marijuana Go To War 

A farm bill battle is pitting hemp against its closest cousin: marijuana. The fight centers on intoxicating hemp products, which have developed into a multi-billion-dollar industry subject to few rules and regulations. Some marijuana companies and trade groups are pushing Congress to close a loophole that allows the production and sale of intoxicating substances derived from legal hemp. The hemp industry has a very different ask for lawmakers: leave the federal definition of hemp unchanged. (Fertig, 5/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF